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1105-171 Hip Ratio Cutoffs Associated With Metabolic Risk 
Factors and Subclinical Coronary Atherosclerosis in 
Nonobese Asymptomatic Men
Khurram Nasir, Romeu Meneghelo, Jose A. Carvalho, Joel B. Braunstein, Wendy S. 
Post, Matthew J. Buddoff, Roger S. Blumenthal, Eduardo Mauricio, Armando Pereirinha, 
Raul D. Santos, Johns Hopkins Medical Institutions, Baltimore, MD, International Group 
for studies on Coronary Calcium, Sao Paulo, Brazil
Background: Obesity is a major coronary heart disease (CHD) risk factor. It is a hetero-
geneous disorder, however, in that the storage depot for excess calories differs widely
between individuals, and abdominal obesity may be a better risk marker. Waist to hip
ratio (WHR) is an important indicator of abdominal obesity. We sought to assess whether
WHR provides additional prognostic information in terms of metabolic risk factors as well
as coronary artery calcification (CAC) as determined by electron-beam tomography
(EBT) among non-obese young men.
Methods & Results: 417 consecutive asymptomatic, non-diabetic males (46±7 yrs;
range 29-65 yrs) with BMI<30 kg/m2 presented for (EBT) between 1999 and 2002 in Sao
Paolo, Brazil. Patients were divided according to quartiles of WHR (table 1). Men in the
lowest WHR quartile (<0.9) had higher concentrations of HDL, lower TG/HDL ratios and
triglycerides concentrations, and lower fasting glucose than those in the remaining three
quartiles (P values <0.05–0.001) (table). Every categorical increase in WHR was associ-
ated with a significant increase in prevalence of CAC (table). After adjusting for all meta-
bolic and conventional risk factors, WHR in the highest quartile (>1.01) independently
predicted CAC (OR: 1.9, 95% CI= 1.1-3.9, p=0.04).
Conclusions: WHR>0.9 is associated with elevated metabolic risk; and a WHR>1.01
independently predicts CAC in non-obese men. These values may prove useful in further
risk stratification among low-risk individuals.
1105-172 Abnormal Vascular Endothelial Function in Cardiac 
Amyloidosis
Karen M. Modesto, Angela Dispenzieri, Sanderson Cauduro, Martha Lacy, Bijoy 
Khanderia, Marek Behlohlavek, Phllip Greipp, Robert Kyle, Jamil Tajik, Morie Gertz, 
Theodore Abraham, Mayo Clinic, Rochester, MN
Background: Autopsy specimens of amyloidosis patients reveal amyloid deposition in
coronary, renal and hepatic vasculature. However, there are no published reports of the
vascular physiology in amyloidosis. We measured flow mediated arterial dilatation in pri-
mary amyloidosis patients (AL) and age matched healthy volunteers (CON).
Methods: Brachial artery reactivity was measured by using a high frequency ultrasound
probe (10MHz) in consecutive AL patients. Patients with hypertension, coronary artery
disease and diabetes were excluded. Brachial artery diameter and Doppler velocity were
imaged at baseline. A blood pressure cuff was applied to the forearm and inflated to 50
mmHg above systolic blood pressure for 5 minutes. Imaging was repeated during and up
to 1 min after cuff release. Changes in vessel diameter and Doppler velocity, before and
immediately after cuff release were calculated.
Results: Vascular reactivity was measured in 64 AL patients and 20 CON. Flow medi-
ated brachial artery reactivity was significantly lower in the AL compared to CON sub-
jects (p<0.001, Table). Vascular function was similar affected in AL patients with (CAL)
and without (NCAL) echocardiographic evidence of cardiac involvement.
Conclusions: This study demonstrates, for the first time, abnormal flow mediated arte-
rial dilatation in AL. This finding suggests abnormal endothelial function in patients with
AL amyloidosis. In AL patients, endothelial dysfunction is independent of cardiac involve-
ment.
1105-173 Impact of In Vivo Generation of 8-Isoprostaglandin F2α 
After a 30-Minute Passive Smoking Exposure on Flow-
Mediated Endothelium-Dependent Dilation of the 
Brachial Artery
Toru Kato, Mitsuaki Isobe, Nobuo Yoshimoto, Tokyo Medical and Dental University, Tokyo, 
Japan, Saitama Medical Center, Kawagoe, Japan
Background: Recently, a 30-minute passive smoking exposure was found to affect
endothelial function, however, the association between smoking-induced production of
free radicals and endothelial dysfunction is to be elucidated.
Methods: We studied 30 healthy Japanese men (mean age 32 years; 15 healthy non-
smokers and 15 asymptomatic smokers) without history of hypertension, diabetes melli-
tus, or hypercholesterolemia. Before and after a 30-minute passive smoking exposure,
we evaluated (1) plasma levels of 8-isoprostaglandin F2α, produced non-enzymatically
by direct oxidation of arachidonic acid in vivo by oxigen free radicals; (2) flow-mediated
endothelium-dependent dilation of the brachial artery by using high-resolution ultra-
sound.
Results: A 30-minute passive smoking exposure (1) significantly increased plasma lev-
els of 8-isoprostaglandin F2α (from 26.9 +/- 5.4 mol/mol to 37.8 +/- 9.6 pmol/mol, p <
0.01); (2) significantly decreased flow-mediated endothelium-dependent dilation of the
brachial artery (from 10.9 +/- 3.1% to 5.0 +/- 1.9%, p < 0.01). However, similar in smokers
(from 41.5 +/- 5.8 mol/mol to 39.2 +/- 9.0 pmol/mol; from 4.3 +/- 1.2% to 3.9 +/- 1.0%,
respectively). Moreover, plasma levels of 8-isoprostaglandin F2α showed a
significant inverse correlation with flow-mediated endothelium-dependent dilation of the
brachial artery
 
(r = -0.69, p < 0.001).
Conclusion: A 30-minute passive smoking exposure rapidly increases production of free
radicals, and impairs flow-mediated endothelium-dependent dilation of the brachial are-
try. These findings warrant nonsmokers should be protected in their workplace and other
public areas from dangerous passive smoking.
1105-174 Increased Body Mass Index Is Associated With Impaired 
Endothelial Function in Women but Not Men: A NOMAS 
Substudy
Cairistine N. Grahame-Clarke, Yumiko Miyake, Robert R. Sciacca, Kumiko Hirata, Carlos 
J. Rodriguez, Bernadette Boden-Albala, Marco Di Tullio, Ralph L. Sacco, Shunichi 
Homma, Columbia-Presbyterian Medical Center, New York, NY
Background: An increased body mass index (BMI) is part of a cluster of cardiovascular
risk factors that make-up the Metabolic Syndrome (MS). This syndrome has a greater
clinical impact on women compared to men the reasons for which are unclear. Endothe-
lial dysfunction as determined by impaired flow-mediated vasodilatation is known to be
associated with an increased body mass index but no sex difference has previously been
reported.
Hypothesis: Increased BMI is associated with impaired flow-mediated vasodilatation in
women more than men.
Method: Flow-mediated dilatation and body mass index (BMI) were determined in a sub-
group (n=843) of the Northern Manhattan Study (NOMAS). All subjects had no previous
cardiovascular event, mean age was 66.5 +-8.8 years and 57% were female. Multiple
regression analysis was performed. Results: BMI was found to be significantly associ-
ated with impaired FMD overall (p=0.0008) and this remained significant after adjusting
for age, hypertension,diabetes, hypercholesterolemia and cigarette smoking (p=0.0006).
BMI was divided into three groups <=25, 25-30 and >30 and FMD showed a dose-
response effect in women (endothelial reactivity being 6.7+-4.0, 5.7+-3.8 and 5.1+-3.7
respectively, p=0.0011) but not in men (6.4+-4.1,5.4+-3.3 and 5.7+-3.7, p=0.21). The dif-
ference between the sexes was not significant (p=0.41) even when adjusting for other
cardiovascular risk factors (p=0.64)
Conclusion: A raised BMI is associated with impaired vasodilatation in women but not in
men. This may potentially explain the gender-based difference in cardiovascular events
risk in those with the Metabolic Syndrome.
1105-175 Incidence of Malignant Ventricular Tachycardia in 
Patients With Prophylactic Defibrillator Implantation 
Does Not Differ From Event Rates in Patients Treated for 
Survived Cardiac Arrest
Ulrich Backenkohler, Ali Erdogan, Mary-Kay Steen-Muller, Klaus Nehmer, Wilhelm 
Stertmann, Bernd Waldecker, Harald Tillmanns, Justus-Liebig-University, Giessen, 
Germany
Background Benefit of prophylactic defibrillator (ICD) implantation compared to conven-
tional treatment in high-risk patients with ischemic cardiomyopathy has been demon-
strated in large hallmark trials (MADIT II, MUSTT). However, many patients have scarce
or no sustained malignant arrhythmias after ICD therapy. The question arises, whether or
not patients with prophylactic therapy have a lower risk of ever getting life-threatening
ventricular tachycardias (VT) or ventricular fibrillation (VF). The purpose of the present
study was to compare incidence, type and treatment of sustained VT or VF after ICD
implantation in patients without previous events to corresponding data of ICD recipients
that had been saved from symptomatic sustained VT or VF.
Methods: Over a period of 4 years post ICD implantation clinical status, arrhythmia mor-
bidity and incidence of ICD therapies of 202 sudden cardiac death survivors (Group A)
were compared to 43 high risk patients who had had prophylactic ICD implantation
(Group B). All patients in Group B had structural heart disease, impaired LVEF of less
than 45%, long runs ( > 6 cycles, < 30s) of nonsustained VT during Holter monitoring and
inducible sustained VT or VF during electrophysiological testing.
Results: Clinical baseline characteristics were not different in both groups. Incidence of
rapid VT/ VF (Cycle length < 240ms) after 4 years (35% in both groups, p=ns) and ade-
quate ICD therapies (57% vs 55%, p=ns) were similar in both groups after univariate and
multivariate analysis. Mean cycle length of VT/VF was longer in Group A than in Group B
patients (310+62ms vs 240+55ms, p<0.05).
Conclusion: During long-term follow-up, incidence of rapid VT/VF is similar in patients
with aborted sudden cardiac death as compared to previously asymptomatic high-risk
patients that have inducible sustained ventricular arrhythmias during electrophysiological
testing prior to ICD implantation. Therefore, ICD implantation for primary prevention of
sudden cardiac death, so far only recognized as a "class II indication", appears to be
essential in high-risk patients.
Age-Adjusted Odds Ratios (95% CI) for risk factors & CAC by level of WHR
WHR 
Quartiles
HDL 
Cholesterol 
<40 mg/dl
Triglycerides 
>150 mg//dl
Fasting blood 
TG/HDL ratio 
>4.6
Fasting blood 
glucose > 110 
mg/dl
CAC (%)
<0.89 1 1 1 1 1
0-90-0.96 1.6 (1.0-3.1) 2.8 (1.6-4.9) 2.9 (1.5-5.9) 2.6 (0.5-13.6) 1.6 (1.0-2.8)
0.97-1.0 1.7 (1.1-3.1) 4.5 (2.4-8.2) 3.1 (1.6-5.8) 5.4 (1.1-26.6) 1.9 (1.1-3.4)
1.01-1.6 2.3 (1.3-4.2) 5.8 (3.1-10.9) 5.9 (2.9-12.1) 8.5 (1.8-40.1) 2.8 (1.5-5.1)
All p values are NCAL and CAL vs CON
CON
(N=20)
NCAL
(N=20)
CAL
(N=64)
p value
Age 61 ±6.5 58 ±8.2 61±10.4 NS
% Males 4( 3%) 7(2%) 7 (3%) NS
Delta change in diameter (FMC) 11.22±7.7 2.97±8.2 1.82±8 <0.0001
